SCHEMBL20093444

SCHEMBL20093444

COc1cc(-c2ccoc2C)c(C)cc1Cl

nearest known ligand 0.47

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
▸ LMNA P02545 2/20 0.47
▸ KDM4E B2RXH2 2/20 0.43
▸ POLB P06746 3/20 0.38
▸ NPC1 O15118 3/20 0.38
▸ GAA P10253 2/20 0.38
▸ HSP90AA1 P07900 2/20 0.37
▸ HSP90AB1 P08238 2/20 0.37
▸ MAPT P10636 4/20 0.35
▸ MEN1 O00255 3/20 0.35
▸ KMT2A Q03164 3/20 0.35
▸ RAB9A P51151 2/20 0.35
▸ CTSA P10619 1/20 0.34
▸ ALDH1A1 P00352 3/20 0.34
▸ HPGD P15428 2/20 0.34
▸ USP2 O75604 1/20 0.34
▸ CYP2C9 P11712 1/20 0.34
▸ ALOX12 P18054 1/20 0.34
▸ MAPK1 P28482 1/20 0.34
▸ CYP2C19 P33261 1/20 0.34
▸ NPSR1 Q6W5P4 1/20 0.34

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL12458505 0.74 GAA (0.41) LMNAKDM4ENPC1GAAHSP90AA1
SCHEMBL19414403 0.72 GAA (0.37) LMNAKDM4EPOLBNPC1GAA
SCHEMBL383766 0.71 GAA (0.54) LMNAKDM4EPOLBNPC1GAA
SCHEMBL91989 0.69 GAA (0.58) LMNAPOLBNPC1GAAHSP90AA1
SCHEMBL27691177 0.68 PGK1 (0.46) LMNAKDM4EPOLBNPC1GAA
SCHEMBL8014964 0.67 — —
SCHEMBL10356771 0.67 GAA (0.54) KDM4EPOLBNPC1GAAHSP90AA1
SCHEMBL14507702 0.66 ACHE (0.46) LMNAKDM4EPOLBGAAMAPT
Chloroneb SCHEMBL22739 0.66 GAA (0.64) KDM4EPOLBNPC1GAAHSP90AA1
SCHEMBL1755249 0.65 NPC1 (0.58) LMNAKDM4EPOLBNPC1GAA

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-10322130-B2 Substituted chromenones as modulators of protein kinases RHIZEN PHARMACEUTICALS SA (CH) 2019-06-18 — — US disclosed
US-20190105324-A9 SUBSTITUTED CHROMENONES AS MODULATORS OF PROTEIN KINASES RHIZEN PHARMACEUTICALS AG (CH) 2019-04-11 — — US disclosed
US-20180110783-A1 NOVEL COMPOUNDS AS MODULATORS OF PROTEIN KINASES RHIZEN PHARMACEUTICALS SA (CH) 2018-04-26 — — US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (3 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20190105324-A9 SUBSTITUTED CHROMENONES AS MODULATORS OF PROTEIN KINASES PRKCA, PRKCH, PRKAR2B LMNA 1256/4885KDM4E 2305/4885POLB 2848/4885
US-20180110783-A1 NOVEL COMPOUNDS AS MODULATORS OF PROTEIN KINASES PRKCA, PRKCH, PRKCB LMNA 2205/4885KDM4E 2926/4885POLB 2194/4885
US-10322130-B2 Substituted chromenones as modulators of protein kinases MAP3K1, CSNK1A1, MAP3K2 LMNA 1218/4885KDM4E 2801/4885POLB 4229/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.

Send feedback